Nanofiber has become one of tissue engineering examples and has extensive application on medical field, particularly as a wound healing and wound dressing. In this research, nanofiber composite based on polycaprolactone and collagen was successfully obtained via electrospinning process and further developed as host of naproxen as anti-inflammatory agents. Addition of copper ferrite (CuFe 2 O 4 ) nanoparticles on the nanocomposite becomes an advance part on this study to control of naproxen release. Several characterizations were furnished to prove the design composite nanofiber and its drug release analysis performed to find out the kinetic model and naproxen release mechanism from nanofibers. CuFe 2 O 4 nanoparticles have potential to be used to control naproxen release in nanofiber that lead to decrease level of drug released, where mostly follow the Korsmeyer-Peppas model. The release of naproxen was certainly influenced by pH value, in which the drug was easier to release on base, instead of acid or neutral condition. Varied naproxen and nanoparticle compositions were prepared to reach optimum formulation of the release. This study provides fundamental data for the effect of magnetic nanoparticle on drug release process.

The physicochemical properties of organo-silica xerogels derived from organo catalyst were pervasively investigated, including the effect of one-step catalyst (citric acid) and two-step catalyst (acid-base), and also to observe the effect of sol pH of organo-silica xerogel toward the structure and deconvolution characteristic. The organo-silica xerogels were characterized by FTIR, TGA and nitrogen sorption to obtain the physicochemical properties. The silica sol–gel method was applied to processed materials by employing TEOS (tetraethyl orthosilicate) as the main precursor. The final molar ratio of organo-silica was 1:38:x:y:5 (TEOS:ethanol: citric acid: NH3:H2O) where x is citric acid concentration (0.1–10 × 10−2 M) and y is ammonia concentration (0 to 3 × 10−3 M). FTIR spectra shows that the one-step catalyst xerogel using citric acid was handing over the higher Si-O-Si concentration as well as Si-C bonding than the dual catalyst xerogels with the presence of a base catalyst. The results exhibited that the highest relative area ratio of silanol/siloxane were 0.2972 and 0.1262 for organo catalyst loading at pH 6 and 6.5 of organo-silica sols, respectively. On the other hand, the organo-silica matrices in this work showed high surface area 546 m2 g−1 pH 6.5 (0.07 × 10−2 N citric acid) with pore size ~2.9 nm. It is concluded that the xerogels have mesoporous structures, which are effective for further application to separate NaCl in water desalination.

No abstract

Mortality and morbidity rates among critically ill septic patients having acute kidney injury (AKI) are very high, considering the total number of deaths after their admission. Inappropriate selection of the type of continuous renal replacement therapy and inadequate therapy become the immediate causes of these issues. Dialysis is a commonly used treatment intended to prolong the life of AKI patients. Dialysis membranes, which are the core of dialysis treatment, must be properly selected to ensure fair treatment to the patients. The accumulation of certain types of molecules must be dealt with using the right membrane. Whether it is low-flux, high-flux, or adsorptive type, the dialysis membrane should be chosen depending on the condition of the patients. The selection of dialysis membranes should also be based on their effect on the treatment outcomes and well-being. All these options are needed to serve the patients of different clinical settings. The use of dialysis membranes is not restricted to conventional haemodialysis, but rather they can be employed in haemoperfusion, haemofiltration, haemodiafiltration, or a combination of any two of them. This review focuses in-depth on different types of dialysis membranes, their characteristics, and approaches in addressing the issues encountered in patients having AKI with sepsis and/or multiorgan failure in intensive care units.